US FDA Suspends All Domestic GMP Surveillance Inspections
Agency responds to COVID-19 pandemic's US arrival by suspending domestic surveillance inspections and non-critical for-cause and preapproval inspections.
Agency responds to COVID-19 pandemic's US arrival by suspending domestic surveillance inspections and non-critical for-cause and preapproval inspections.